September 01, 2025
PBS Listing for popular CGRP treatment not proceeding at this time
Migraine Australia has been advised that discussions between Novartis and the Australian Government have not reached an agreement to list Aimovig® (erenumab) on the Pharmaceutical Benefits Scheme (PBS).
Read more